All stocks Β· APPL
AP

Aptus Pharma Limited

APPL BSE Medical Distribution Healthcare

Aptus Pharma Limited engages in the marketing and distribution of finished pharmaceutical formulations. The company operates through four divisions: Aptus Pharma, Pioneer division, which includes marketing of acute ther…

ISIN INE15XJ01010
Listed β€”
Quarters tracked β€”
Filings 5 docs

About

Aptus Pharma Limited engages in the marketing and distribution of finished pharmaceutical formulations. The company operates through four divisions: Aptus Pharma, Pioneer division, which includes marketing of acute therapies including general anti-infectives, pain management, antacids, and gastrointestinal drugs; Aptus CD Care, Cardiac Diabetic division, which includes marketing of chronic therapies, including antihypertensive, anti-diabetic, and lipid-lowering; Aptus Wellcare offers wellness and nutraceutical products, over-the-counter (OTC) formulations, and personal care products; and Aptus Global, export division engages in exploring and developing opportunities in overseas markets, semi-regulated and emerging countries. It also offers anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, antidiabetic, lipid-lowering, and general wellness products. In additio, the company develops and markets skin care, face care, hair care, personal hygiene, wellness, and self-care over-the-counter products. Its products are available in balms, capsules, drops, gels, injections, lotions, ointments, powders, sachets, softgels, solutions, suspensions, syrups, tablets, and vials. It distributes the products through clearing and forwarding agents. Aptus Pharma Limited was incorporated in 2010 and is headquartered in Rajkot, India.

Quarterly Results

No quarterly results synced yet for this stock.

Data is backfilled from screener.in β€” check back soon.

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023
Sales 46.5624.5617.8113.90
Expenses 39.1119.7116.2713.28
Operating Profit 7.454.851.540.62
OPM % 16.0019.758.654.46
Other Income 0.130.080.030.00
Interest 0.800.470.240.14
Depreciation 0.410.270.210.18
Profit before tax 6.374.191.120.30
Tax % 27.4726.0128.5733.33
Net Profit 4.623.100.800.19
EPS in Rs 2.692.4810.002.38
Dividend Payout % 0.000.000.000.00

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023
Equity Capital 6.865.000.300.30
Reserves 16.491.971.470.67
Borrowings 7.1810.365.312.22
Other Liabilities 13.014.592.953.02
Total Liabilities 43.5421.9210.036.21
Fixed Assets 2.770.990.630.52
CWIP 0.000.000.000.00
Investments 0.000.000.000.00
Other Assets 40.7720.939.405.69
Total Assets 43.5421.9210.036.21

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023
Cash from Operating Activity -5.60-1.84-2.17-0.18
Cash from Investing Activity -6.37-0.54-0.30-0.35
Cash from Financing Activity 7.796.682.860.81
Net Cash Flow -4.194.300.380.28
Free Cash Flow -7.79-2.46-2.50-0.53
CFO/OP % -59.00-15.00-119.00-10.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023
Debtor Days 147.0783.8268.6663.02
Inventory Days 231.78285.06183.57176.00
Days Payable 139.3752.8972.25104.07
Cash Conversion Cycle 239.47315.98179.97134.95
Working Capital Days 116.8136.4167.0251.99
ROCE % 29.9638.1826.48β€”

Shareholding Pattern

% holding β€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025
Promoters 72.89 72.89 72.89 72.89
FIIs 0.00 0.00 0.00 10.03
DIIs 0.00 0.00 0.00 2.80
Public 27.11 27.11 27.11 14.29
No. of Shareholders 686 337 302 213

Corporate Actions

1 records
ActionEx DateRecord DateRatioAmount (β‚Ή)Notes
Bonus 12 May 2026 12 May 2026 3:2 β€”

Announcements

5 filings